KORU Medical CTO files Form 3 with zero shares

KORU Medical Systems, Inc. filed a Form 3 for Chief Technology Officer Eric Schiller reporting his initial beneficial ownership in the company.

Accepted by SEC EDGAR 01/15/2026 - 03:53 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

KORU Medical Systems, Inc. filed a Form 3 for Chief Technology Officer Eric Schiller reporting his initial beneficial ownership in the company. As of the event date of 12/29/2025, the filing shows he beneficially owns 0 shares of common stock, held directly. A Form 3 is an initial statement of ownership that insiders must file when they become subject to reporting rules.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schiller Eric

Role Chief Technology Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the KORU Medical Systems (KRMD) Form 3 for Eric Schiller report?

The Form 3 reports that Chief Technology Officer Eric Schiller beneficially owns 0 shares of KORU Medical Systems, Inc. common stock as of 12/29/2025.

What is Eric Schillers role at KORU Medical Systems (KRMD)?

Eric Schiller is reported as an officer of KORU Medical Systems, Inc., serving as the companys Chief Technology Officer.

Is the insider ownership reported on this Form 3 direct or indirect?

The filing shows direct (D) beneficial ownership, with 0 shares of common stock listed and no indirect ownership arrangements described.

Does this Form 3 for KORU Medical Systems (KRMD) report any derivative securities?

No derivative securities are listed in Table II of the Form 3; the table appears without any derivative holdings for Eric Schiller.

Why is a Form 3 filed for KORU Medical Systems Chief Technology Officer?

A Form 3 is an initial statement of beneficial ownership that must be filed when an individual, such as a Chief Technology Officer, becomes an insider subject to reporting requirements.

Who signed the Form 3 related to KORU Medical Systems (KRMD)?

The Form 3 is signed /s/ Thomas Adams, Attorney-In-Fact, indicating it was executed under a power of attorney filed as Exhibit 24.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Schiller Eric

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NJ 07430

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/29/2025

3. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Power of Attorney filed herewith as Exhibit 24.

	/s/ Thomas Adams Attorney-In-Fact	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.